Investigative Ophthalmology & Visual Science · 2016 · 50 citations · 40 references
MedicineOphthalmologyPharmacologyApoptosisOcular DiseaseSignal TransductionDiabetic RetinopathyNeuroprotectionRetinal DegenerationRetinal Vascular DiseaseAdenylate Cyclase SignalingAdvanced Glycation End ProductsDiabetic ComplicationsNeuroprotective AgentsNeuroprotective SignalingRetinal NeuroprotectionSurvival Factor SignalingVascular Endothelial Growth Factor
PURPOSE: Growing evidence indicates neuroprotection as a therapeutic target in diabetic retinopathy (DR). We tested the hypothesis that VEGF is released and acts as a survival factor in the retina in early DR. METHODS: Ex vivo mouse retinal explants were exposed to stressors similar to those characterizing DR, that is, high glucose (HG), oxidative stress (OS), or advanced glycation end-products (AGE). Neuroprotection was provided using octreotide (OCT), a somatostatin analog, and pituitary adenylate cyclase activating peptide (PACAP), two well-documented neuroprotectants. Data were obtained with real-time RT-PCR, Western blot, ELISA, and immunohistochemistry. RESULTS: Apoptosis was induced in the retinal explants by HG, OS, or AGE treatments. At the same time, explants also showed increased VEGF expression and release. The data revealed that VEGF is released shortly after exposure of the explants to stressors and before the level of cell death reaches its maximum. Retinal cell apoptosis was inhibited by OCT and PACAP. At the same time, OCT and PACAP also reduced VEGF expression and release. Vascular endothelial growth factor turned out to be a protective factor for the stressed retinal explants, because inhibiting VEGF with a VEGF trap further increased cell death. CONCLUSIONS: These data show that protecting retinal neurons from diabetic stress also reduces VEGF expression and release, while inhibiting VEGF leads to exacerbation of apoptosis. These observations suggest that the retina in early DR releases VEGF as a prosurvival factor. Neuroprotective agents may decrease the need of VEGF production by the retina, therefore limiting the risk, in the long term, of pathologic angiogenesis.
40
Autocrine VEGF Signaling Is Required for Vascular Homeostasis
Sunyoung Lee, Tom T. Chen, Chad L. Barber et al. · Cell · 2007 · 1K citations · Full text
David A. Antonetti, Alistair J. Barber, Sarah K. Bronson et al. · Diabetes · 2006 · 738 citations